Zobrazeno 1 - 4
of 4
pro vyhledávání: '"G. D. Frost"'
Publikováno v:
Journal of Medical Economics. 1:1-18
SummaryAsthma is an important disease for New Zealand in terms of prevalence and costs, both direct and indirect. The objective of this study was to determine if there were any differences in primary care medical costs between treatment of asthma wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9157ef1511320b2a894d1fef06f8a2ce
https://doi.org/10.3111/199801001018
https://doi.org/10.3111/199801001018
Autor:
G D, Frost
Publikováno v:
LDA journal. 52(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::357c1201a2b130a33ee3c5137ab47381
https://pubmed.ncbi.nlm.nih.gov/15307275
https://pubmed.ncbi.nlm.nih.gov/15307275
Publikováno v:
BMJ. 319:385-385
EDITOR—We were surprised to see the relation between people's sex and, in those with asthma, their likelihood of being prescribed oral steroids, as found by Sexton et al.1 We analysed a larger dataset, as they suggest. We included computerised 1996
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94ec861125e15d7805c4f5846c12b4b7
https://doi.org/10.1136/bmj.319.7206.385
https://doi.org/10.1136/bmj.319.7206.385
Publikováno v:
Respiratory Medicine. (12):1352-1358
Four types of corticosteroid inhaler devices are available in New Zealand for first-line treatment of asthma, including two aerosol systems [Autohaler (3M Healthcare Ltd, Loughborough, U.K.; 3M Pharmaceuticals (Australia Pty Ltd, Sydney, Australia) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e64580c8233379d158612a84026e0768